Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).


Market Analysis and Insights: Global Drugs for Schistosomiasis Market
In 2020, the global Drugs for Schistosomiasis market size was US$ 79 million and it is expected to reach US$ 102.8 million by the end of 2027, with a CAGR of 3.8% during 2021-2027.
Global Drugs for Schistosomiasis Scope and Market Size
Drugs for Schistosomiasis market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Drugs for Schistosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Drugs for Schistosomiasis market is segmented into
Praziquantel
Oxamniquine
Other

Segment by Application, the Drugs for Schistosomiasis market is segmented into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Drugs for Schistosomiasis Market Share Analysis
Drugs for Schistosomiasis market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Drugs for Schistosomiasis product introduction, recent developments, Drugs for Schistosomiasis sales by region, type, application and by sales channel.

The major companies include:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals